{
    "2019-10-15": [
        [
            {
                "time": "",
                "orginal_text": "一针上千块成本才二十，玻尿酸厂家毛利率常年90%，如今争相IPO",
                "features": {
                    "keywords": [
                        "玻尿酸",
                        "毛利率",
                        "IPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗美容",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "行业观察 | 华熙生物：玻尿酸“隐形冠军”的科创板之路",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "玻尿酸",
                        "科创板"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗美容",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}